Esketamine Nasal Spray: Effective Treatment for Depression

Key Points About Esketamine Nasal Spray

Esketamine nasal spray is a prescription medication primarily prescribed for the treatment of depression, including cases of treatment-resistant depression and certain other mental health conditions. This medication works by targeting specific brain chemicals to help improve mood and reduce symptoms. Typically, esketamine is used in combination with other antidepressants to enhance its effectiveness. It is crucial to follow your healthcare provider’s instructions when using this medication. For personalized advice, consider consulting one of our telemedicine providers.

Medication Names

US Brand Name: Spravato

Generic Name: Esketamine

The generic name, esketamine, refers to the active ingredient in the medication and is often listed alongside its brand name.

Pharmacologic Category

Esketamine nasal spray falls into the following pharmacologic categories:

1. N-methyl-D-aspartate (NMDA) receptor antagonist
2. Antidepressant

Esketamine Dosing Guidelines

Esketamine nasal spray is approved for use in adults to treat various mental health conditions. The dosing schedule may differ depending on the specific condition being addressed. Always adhere to your healthcare provider’s instructions and consult them before making any changes to your dosage. For additional support, you can schedule a telemedicine visit with one of our providers.

Depression and Major Depressive Disorder (MDD)

Initial Dose: 56 mg administered intranasally (via the nose) twice a week for the first 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5-8, followed by every 1-2 weeks thereafter.

Treatment-Resistant Depression (TRD)

Initial Dose: 56 mg administered intranasally twice a week for the first 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5-8, followed by every 1-2 weeks thereafter.

Anxiety Disorders

Initial Dose: 56 mg administered intranasally twice a week for 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5-8, followed by every 1-2 weeks thereafter.

Post-Traumatic Stress Disorder (PTSD)

Initial Dose: 56 mg administered intranasally twice a week for 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5-8, followed by every 1-2 weeks thereafter.

Obsessive-Compulsive Disorder (OCD)

Initial Dose: 56 mg administered intranasally twice a week for 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5-8, followed by every 1-2 weeks thereafter.

Bipolar Disorder

Initial Dose: 56 mg administered intranasally twice a week for 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5-8, followed by every 1-2 weeks thereafter.

Chronic Pain

Initial Dose: 56 mg administered intranasally twice a week for 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5-8, followed by every 1-2 weeks thereafter.

Suicidal Ideation

Initial Dose: 84 mg administered intranasally twice a week for 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5-8, followed by every 1-2 weeks thereafter.

Seasonal Affective Disorder (SAD)

Initial Dose: 56 mg administered intranasally twice a week for 4 weeks.

Maintenance Dose: 56 mg or 84 mg once weekly during weeks 5-8, followed by every 1-2 weeks thereafter.

Dosage Forms and Strengths

Esketamine nasal spray is available in the following dosage form:

1. 28 mg nasal spray (each device contains 28 mg of esketamine)

Administration Instructions for Esketamine Nasal Spray

Esketamine nasal spray is administered under the supervision of a healthcare provider in a certified medical office or clinic. Patients should avoid driving or operating heavy machinery for at least 24 hours after receiving a dose. While the nasal spray is self-administered, patients are closely monitored for at least two hours after each dose to ensure their safety. Always follow your healthcare provider’s instructions carefully.

Contraindications for Esketamine Nasal Spray

A contraindication refers to a specific condition or circumstance in which a medication should not be used because it may cause harm. For Esketamine nasal spray, there are several situations where its use is not recommended.

Uncontrolled high blood pressure (hypertension): Esketamine can cause a temporary increase in blood pressure, which may be dangerous for individuals with poorly managed hypertension.

History of aneurysms or brain hemorrhages: Because Esketamine can elevate blood pressure, it may heighten the risk of brain bleeding or the rupture of an aneurysm.

Severe liver disease: Esketamine is processed by the liver. Individuals with significant liver impairment may have difficulty metabolizing the drug, which could lead to increased side effects or toxicity.

Hypersensitivity to esketamine or ketamine: If you have ever had an allergic reaction to Esketamine or ketamine, you should avoid using this medication.

Pregnancy or breastfeeding: Esketamine may pose risks to a developing fetus or a nursing infant. Additional details are provided in the sections below.

Drug-to-Drug Interactions with Esketamine Nasal Spray

Using Esketamine nasal spray alongside other medications can increase the likelihood of side effects or reduce the effectiveness of treatment. It is essential to inform your healthcare provider about all medications you are currently taking. Below are some known interactions:

1. Benzodiazepines (e.g., Xanax [alprazolam], Valium [diazepam]): These medications may amplify sedation when combined with Esketamine.
2. Opioids (e.g., OxyContin [oxycodone], Vicodin [hydrocodone/acetaminophen]): Taking Esketamine with opioids increases the risk of excessive sedation and respiratory depression.
3. Monoamine oxidase inhibitors (MAOIs) (e.g., Nardil [phenelzine], Parnate [tranylcypromine]): Combining MAOIs with Esketamine may result in severe side effects, such as dangerously high blood pressure.
4. Stimulants (e.g., Adderall [amphetamine/dextroamphetamine], Ritalin [methylphenidate]): Stimulants can further increase the risk of elevated blood pressure when used with Esketamine.
5. Alcohol: Consuming alcohol while using Esketamine can intensify sedation and impair cognitive and motor functions.

Esketamine Nasal Spray During Pregnancy

Is it safe to take Esketamine nasal spray when pregnant?

There is limited research on the safety of Esketamine nasal spray during pregnancy. Animal studies have indicated potential risks to the fetus, including developmental abnormalities. For this reason, Esketamine is generally not recommended during pregnancy unless the potential benefits significantly outweigh the risks. If you are pregnant or planning to become pregnant, consult your healthcare provider to explore your treatment options. You can also schedule a telemedicine appointment with one of our professionals for personalized guidance.

Esketamine Nasal Spray While Breastfeeding

Is it safe to take Esketamine nasal spray while breastfeeding?

There is currently insufficient information to determine whether Esketamine nasal spray passes into breast milk or its potential effects on a nursing infant. Due to the possibility of serious side effects in newborns, it is generally advised to avoid using Esketamine while breastfeeding. If you are breastfeeding or planning to breastfeed, discuss the risks and benefits with your healthcare provider. Alternative treatments can also be explored with one of our telemedicine providers.

Estimated Cost of Esketamine Nasal Spray Treatment

The cost of Esketamine nasal spray can vary depending on your location and pharmacy. Without insurance, a 30-day supply typically ranges from $590 to $885 when using a GoodRx coupon. To help manage costs, check with your pharmacy and explore available discounts or patient assistance programs.

Possible Alternatives to Esketamine Nasal Spray

If Esketamine nasal spray is not the right option for you, there are other treatments and lifestyle changes that may help manage your condition. It’s important to consult your healthcare provider before making any changes to your treatment plan. You can also schedule a telemedicine visit with one of our providers to discuss these alternatives in detail.

Depression Treatment Options

Depression: Alternatives to Esketamine include selective serotonin reuptake inhibitors (SSRIs), such as Prozac (fluoxetine), or serotonin-norepinephrine reuptake inhibitors (SNRIs), like Cymbalta (duloxetine). Cognitive-behavioral therapy (CBT) is another effective option, often used alongside lifestyle changes like regular physical activity and a nutritious, balanced diet to help alleviate symptoms.

Esketamine for Major Depressive Disorder (MDD) and Other Alternatives

Major Depressive Disorder (MDD): In addition to SSRIs and SNRIs, other options include tricyclic antidepressants (TCAs) or atypical antidepressants, such as Wellbutrin (bupropion). Psychotherapy, particularly evidence-based approaches like CBT or interpersonal therapy, remains a cornerstone of treatment for MDD.

Treatment-Resistant Depression Therapy Options

Treatment-Resistant Depression: For individuals who do not respond to standard antidepressants, alternative therapies include electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS). Medications such as Abilify (aripiprazole) or Rexulti (brexpiprazole) may also be prescribed to augment existing treatments.

Anxiety Disorders and Related Treatments

Anxiety Disorders: SSRIs, such as Zoloft (sertraline), are often the first-line treatment for anxiety. For short-term relief, benzodiazepines like Klonopin (clonazepam) may be considered, though they are typically used with caution due to the risk of dependency. Non-medication approaches, including mindfulness practices and CBT, are also highly effective in managing anxiety symptoms.

Post-Traumatic Stress Disorder (PTSD) Treatment Options

Post-Traumatic Stress Disorder (PTSD): Treatment options for PTSD often include SSRIs like Paxil (paroxetine) and trauma-focused psychotherapy. Eye movement desensitization and reprocessing (EMDR) therapy has also shown significant benefits in helping individuals process and recover from traumatic experiences.

Obsessive-Compulsive Disorder (OCD) Therapies

Obsessive-Compulsive Disorder (OCD): SSRIs, such as Lexapro (escitalopram), or clomipramine, a tricyclic antidepressant, are commonly prescribed for OCD. Behavioral therapies, particularly exposure and response prevention (ERP), are highly effective in reducing obsessive thoughts and compulsive behaviors.

Bipolar Disorder Management

Bipolar Disorder: Treatment for bipolar disorder often involves mood stabilizers like Lithobid (lithium) or antipsychotic medications such as Seroquel (quetiapine). Psychotherapy, combined with lifestyle strategies like maintaining a consistent sleep schedule and managing stress, plays a critical role in long-term management.

Chronic Pain and Depression Nasal Spray Therapy Alternatives

Chronic Pain: For individuals experiencing chronic pain, non-opioid medications such as Lyrica (pregabalin) or Cymbalta (duloxetine) may provide relief. Complementary therapies, including physical therapy, acupuncture, and mindfulness-based stress reduction (MBSR), can also be effective in managing pain and improving quality of life.

Suicidal Ideation: Immediate Treatment Options

Suicidal Ideation: Immediate intervention is essential for individuals experiencing suicidal thoughts. In addition to Esketamine, treatment options include hospitalization, crisis intervention, and medications such as antipsychotics or mood stabilizers. Psychotherapy, along with the development of a personalized safety plan, is a critical part of care.

Seasonal Affective Disorder (SAD) Treatments

Seasonal Affective Disorder (SAD): Light therapy is a widely recommended treatment for SAD, often used alongside SSRIs like Zoloft (sertraline). Lifestyle changes, such as increasing exposure to natural sunlight and engaging in regular physical activity, can also help improve symptoms.

Recent Updates on Esketamine Nasal Spray Research

Recent studies continue to explore the long-term effects and benefits of Esketamine nasal spray, particularly for treatment-resistant depression and suicidal ideation. A 2022 study published in the Journal of Clinical Psychiatry found that Esketamine, when combined with oral antidepressants, significantly reduced depression symptoms in patients who had not responded to other treatments. Additionally, ongoing research is investigating its potential applications for other mental health conditions, including PTSD and anxiety disorders.

As new findings emerge, staying informed about the latest research is essential. If you have questions about how these updates might affect your treatment plan, consider scheduling a telemedicine appointment with one of our providers today.

James Kingsley

Learn More